NCT07211152View on ClinicalTrials.gov

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions
Influenza
Interventions
BIOLOGICAL

Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

BIOLOGICAL

Vaxigrip QIV

Participants will receive one dose of vaccine (0.5 mL) of Vaxigrip QIV

Trial Locations (2)

Unknown

Health Cube Medical Clinics, Mandaluyong

University of the Philippines - Philippine General Hospital (UP-PGH), Manila

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY